Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia.

Peter Tan, Andrew Wei

Research output: Contribution to journalLetterOther

2 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)675 - 676
Number of pages2
JournalLeukemia and Lymphoma
Volume54
Issue number4
DOIs
Publication statusPublished - 2013

Cite this